Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Cilostazol")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 262

  • Page / 11
Export

Selection :

  • and

Long-term safety of cilostazol in patients with peripheral artery disease : The CASTLE study (Cilostazol: A Study in Long-term Effects)HIATT, William R; MONEY, Samuel R; BRASS, Eric P et al.Journal of vascular surgery. 2008, Vol 47, Num 2, pp 330-336, issn 0741-5214, 7 p.Article

The pharmacokinetics of cilostazolCREAGER, Mark A.Clinical pharmacokinetics. 1999, Vol 37, issn 0312-5963, 98 p., SUP2Serial Issue

Cilostazol reduces restenosis after carotid artery stentingTAKIGAWA, Tomoji; MATSUMARU, Yuji; HAYAKAWA, Mikito et al.Journal of vascular surgery. 2010, Vol 51, Num 1, pp 51-56, issn 0741-5214, 6 p.Article

Antiplatelet agent cilostazol potentiates adipocyte differentiation of 3T3-L1 cellsHIROSE, Takahisa; KUREBAYASHI, Shogo; KASAYAMA, Soji et al.Atherosclerosis. 2001, Vol 158, Num 1, pp 19-22, issn 0021-9150Article

Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemiaSOGA, Yoshimitsu; IIDA, Osamu; HIRANO, Keisuke et al.Journal of vascular surgery. 2011, Vol 54, Num 6, pp 1659-1667, issn 0741-5214, 9 p.Article

Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cellsTAKIGAWA, Tomoji; TSURUSHIMA, Hideo; SUZUKI, Kensuke et al.Journal of vascular surgery. 2012, Vol 55, Num 2, pp 506-516, issn 0741-5214, 11 p.Article

The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication : A randomized controlled trial. DiscussionHOBBS, Simon D; MARSHALL, Tim; FEGAN, Chris et al.Journal of vascular surgery. 2007, Vol 45, Num 1, pp 65-70, issn 0741-5214, 6 p.Article

Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in ratsSO YOUN PARK; JEONG HYUN LEE; CHI DAE KIM et al.Brain research. 2007, Vol 1157, pp 112-120, issn 0006-8993, 9 p.Article

Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesionsIIDA, Osamu; NANTO, Shinsuke; UEMATSU, Masaaki et al.Journal of vascular surgery. 2008, Vol 48, Num 1, pp 144-149, issn 0741-5214, 6 p.Article

Cilostazol Ameliorates Nephropathy in Type 1 Diabetic Rats Involving Improvement in Oxidative Stress and Regulation of TGF-β and NF-KBLEE, Wen-Chin; CHEN, Hong-Chen; WANG, Chih-Ying et al.Bioscience, biotechnology, and biochemistry. 2010, Vol 74, Num 7, pp 1355-1361, issn 0916-8451, 7 p.Article

Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusionJEONG HYUN LEE; SO YOUN PARK; YUNG WOO SHIN et al.Brain research. 2006, Vol 1082, pp 182-191, issn 0006-8993, 10 p.Article

Rationale and design of the randomized, multicenter, Cilostazol for RESTenosis (CREST) trialDOUGLAS, John S; WEINTRAUB, William S; HOLMES, David et al.Clinical cardiology (Mahwah, NJ). 2003, Vol 26, Num 10, pp 451-454, issn 0160-9289, 4 p.Article

Benefit, rather than safety, of cilostazol for long-term mortality in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trialsTAKAGI, Hisato; UMEMOTO, Takuya.International journal of cardiology. 2011, Vol 153, Num 1, pp 74-76, issn 0167-5273, 3 p.Article

Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with peripheral vascular diseaseNAKAMURA, N; HAMAZAKI, T; YAMABE, H et al.Clinical and experimental medicine (Testo stampato). 2003, Vol 2, Num 4, pp 180-184, issn 1591-8890, 5 p.Article

Thermally-prepared polymorphic forms of cilostazolSTOWELL, Grayson W; BEHME, Robert J; DENTON, Stacy M et al.Journal of pharmaceutical sciences. 2002, Vol 91, Num 12, pp 2481-2488, issn 0022-3549, 8 p.Article

Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive ratsFUJITA, Youshi; LIN, J.-Xi; TAKAHASHI, Ryosuke et al.Brain research. 2008, Vol 1203, pp 170-176, issn 0006-8993, 7 p.Article

HPLC determination of cilostazol in tablets, and its validationARDHANI DWI LESTARI; PALUPI, Tini; OKTARINA, Bertha et al.Journal of liquid chromatography & related technologies. 2004, Vol 27, Num 16, pp 2603-2612, issn 1082-6076, 10 p.Article

Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudicationTAO WANG; EIAM, Marshall B; FORBES, William P et al.Atherosclerosis. 2003, Vol 171, Num 2, pp 337-342, issn 0021-9150, 6 p.Article

Meta-Analysis of Randomized Controlled Trials on Effect of Cilostazol on Restenosis Rates and Outcomes After Percutaneous Coronary InterventionFRIEDLAND, Sayuri N; EISENBERG, Mark J; SHIMONY, Avi et al.The American journal of cardiology. 2012, Vol 109, Num 10, pp 1397-1404, issn 0002-9149, 8 p.Article

Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: A meta-analysis of randomized trialsSCHLEINITZ, Mark D; OLKIN, Ingram; HEIDENREICH, Paul A et al.The American heart journal. 2004, Vol 148, Num 6, pp 990-997, issn 0002-8703, 8 p.Article

Comparison of ticlopidine and cilostazol for the prevention of restenosis after percutaneous transluminal coronary angioplastyNAGAOKA, Noriyasu; MATSUBARA, Tatsuaki; OKAZAKI, Katsuo et al.Japanese heart journal. 2001, Vol 42, Num 1, pp 43-54, issn 0021-4868Article

Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in ratsTANI, Takeshi; UEHARA, Kenji; SUDO, Toshiki et al.Atherosclerosis. 2000, Vol 152, Num 2, pp 299-305, issn 0021-9150Article

Effect of Cilostazol in preventing restenosis after percutaneous transluminal coronary angioplastyTAKE, S; MATSUTANI, M; UEDA, H et al.The American journal of cardiology. 1997, Vol 79, Num 8, pp 1097-1099, issn 0002-9149Article

Cilostazol promotes survival of axotomized retinal ganglion cells in adult ratsKASHIMOTO, Ryosuke; KURIMOTO, Takuji; MIYOSHI, Tomomitsu et al.Neuroscience letters. 2008, Vol 436, Num 2, pp 116-119, issn 0304-3940, 4 p.Article

Cilostazol treatment of claudication in diabetic patientsRENDELL, Marc; CARISKI, Alan T; HITTEL, Norbert et al.Current medical research and opinion. 2002, Vol 18, Num 8, pp 479-487, issn 0300-7995, 9 p.Article

  • Page / 11